These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 21242790

  • 1. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials.
    Kamel H, Navi BB, Nakagawa K, Hemphill JC, Ko NU.
    Crit Care Med; 2011 Mar; 39(3):554-9. PubMed ID: 21242790
    [Abstract] [Full Text] [Related]

  • 2. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
    Chen H, Song Z, Dennis JA.
    Cochrane Database Syst Rev; 2020 Jan 17; 1(1):CD010904. PubMed ID: 31978260
    [Abstract] [Full Text] [Related]

  • 3. Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials.
    Gu J, Huang H, Huang Y, Sun H, Xu H.
    Neurosurg Rev; 2019 Jun 17; 42(2):499-509. PubMed ID: 29905883
    [Abstract] [Full Text] [Related]

  • 4. Hypertonic saline and mannitol in patients with traumatic brain injury: A systematic and meta-analysis.
    Shi J, Tan L, Ye J, Hu L.
    Medicine (Baltimore); 2020 Aug 28; 99(35):e21655. PubMed ID: 32871879
    [Abstract] [Full Text] [Related]

  • 5. Salt or sugar for your injured brain? A meta-analysis of randomised controlled trials of mannitol versus hypertonic sodium solutions to manage raised intracranial pressure in traumatic brain injury.
    Rickard AC, Smith JE, Newell P, Bailey A, Kehoe A, Mann C.
    Emerg Med J; 2014 Aug 28; 31(8):679-83. PubMed ID: 23811861
    [Abstract] [Full Text] [Related]

  • 6. Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
    Chen H, Song Z, Dennis JA.
    Cochrane Database Syst Rev; 2019 Dec 30; 12(12):CD010904. PubMed ID: 31886900
    [Abstract] [Full Text] [Related]

  • 7. Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries.
    Sakellaridis N, Pavlou E, Karatzas S, Chroni D, Vlachos K, Chatzopoulos K, Dimopoulou E, Kelesis C, Karaouli V.
    J Neurosurg; 2011 Feb 30; 114(2):545-8. PubMed ID: 21087203
    [Abstract] [Full Text] [Related]

  • 8. Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury.
    Kumar SA, Devi BI, Reddy M, Shukla D.
    Childs Nerv Syst; 2019 Jun 30; 35(6):999-1005. PubMed ID: 30879126
    [Abstract] [Full Text] [Related]

  • 9. A Systematic Review of Randomized Controlled Trials Comparing Hypertonic Sodium Solutions and Mannitol for Traumatic Brain Injury: Implications for Emergency Department Management.
    Burgess S, Abu-Laban RB, Slavik RS, Vu EN, Zed PJ.
    Ann Pharmacother; 2016 Apr 30; 50(4):291-300. PubMed ID: 26825644
    [Abstract] [Full Text] [Related]

  • 10. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline.
    Qureshi AI, Wilson DA, Traystman RJ.
    Neurosurgery; 1999 May 30; 44(5):1055-63; discussion 1063-4. PubMed ID: 10232539
    [Abstract] [Full Text] [Related]

  • 11. Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury.
    Huang X, Yang L, Ye J, He S, Wang B.
    Medicine (Baltimore); 2020 Sep 18; 99(38):e22004. PubMed ID: 32957318
    [Abstract] [Full Text] [Related]

  • 12. Hypertonic Saline Versus Mannitol for Traumatic Brain Injury: A Systematic Review and Meta-analysis With Trial Sequential Analysis.
    Schwimmbeck F, Voellger B, Chappell D, Eberhart L.
    J Neurosurg Anesthesiol; 2021 Jan 18; 33(1):10-20. PubMed ID: 31567726
    [Abstract] [Full Text] [Related]

  • 13. Mannitol versus hypertonic saline for brain relaxation in patients undergoing craniotomy.
    Prabhakar H, Singh GP, Anand V, Kalaivani M.
    Cochrane Database Syst Rev; 2014 Jul 16; 2014(7):CD010026. PubMed ID: 25019296
    [Abstract] [Full Text] [Related]

  • 14. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
    Kerwin AJ, Schinco MA, Tepas JJ, Renfro WH, Vitarbo EA, Muehlberger M.
    J Trauma; 2009 Aug 16; 67(2):277-82. PubMed ID: 19667879
    [Abstract] [Full Text] [Related]

  • 15. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension?
    Infanti JL.
    J Neurosci Nurs; 2008 Dec 16; 40(6):362-8. PubMed ID: 19170304
    [Abstract] [Full Text] [Related]

  • 16. New trends in hyperosmolar therapy?
    Diringer MN.
    Curr Opin Crit Care; 2013 Apr 16; 19(2):77-82. PubMed ID: 23385373
    [Abstract] [Full Text] [Related]

  • 17. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol.
    Vialet R, Albanèse J, Thomachot L, Antonini F, Bourgouin A, Alliez B, Martin C.
    Crit Care Med; 2003 Jun 16; 31(6):1683-7. PubMed ID: 12794404
    [Abstract] [Full Text] [Related]

  • 18. Hypertonic saline for brain relaxation and intracranial pressure in patients undergoing neurosurgical procedures: a meta-analysis of randomized controlled trials.
    Shao L, Hong F, Zou Y, Hao X, Hou H, Tian M.
    PLoS One; 2015 Jun 16; 10(1):e0117314. PubMed ID: 25635862
    [Abstract] [Full Text] [Related]

  • 19. Evidence for Mannitol as an Effective Agent Against Intracranial Hypertension: An Individual Patient Data Meta-analysis.
    Poole D, Citerio G, Helbok R, Ichai C, Meyfroidt G, Oddo M, Payen JF, Stocchetti N.
    Neurocrit Care; 2020 Feb 16; 32(1):252-261. PubMed ID: 31264071
    [Abstract] [Full Text] [Related]

  • 20. Salt or sugar on the brain: does it matter except for taste?
    Stubbe HD.
    Crit Care Med; 2011 Mar 16; 39(3):601-2. PubMed ID: 21330867
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.